Obesity and the risk of spontaneous abortion after oocyte donation

Fertility and Sterility

Volumn 79, Issue 5, 2003, Pages 1136-1140

  Bellver, José ^a   Rossal, Luis P ^a   Bosch, Ernesto ^a   Zúñiga, Andrés ^b   Corona, José T ^b   Meléndez, Fernando ^c   Gómez, Emilio ^c   Simón, Carlos ^a,d   Remohí, José ^a,d   Pellicer, Antonio ^a,d,e  

^a INSTITUTO VALENCIANO DE INFERTILIDAD   (Spain)

^b Reproductive Endocrinology   (Spain)

^c IVI Murcia   (Spain)

^d UNIVERSITY OF VALENCIA   (Spain)

^e HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

Abortion; Body mass index; Obesity; Oocyte donation

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ADULT; ANALYTICAL PARAMETERS; ARTICLE; BODY MASS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMBRYO; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; OBESITY; OOCYTE DONATION; PREGNANCY; PRIORITY JOURNAL; RECIPIENT; RECURRENT ABORTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SPAIN; SPONTANEOUS ABORTION; UTERUS DISEASE;

EID: 0038639042     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(03)00176-6     Document Type: Article

References (52)

1. Ferraro R., Lillioja S., Fontvieille A.M., Rising R., Bogardus C., Ravussin E. Lower sedentary metabolic rate in women compared with men. J Clin Invest. 90:1992;780-784.
2. Manson J.E., Willett W.C., Stampfer M.J., Colditz G.A., Hunter D.J., Hankinson S.E., et al. Body weight and mortality among women. N Engl J Med. 333:1995;677-685.
3. Colditz G.A., Willett W.C., Rotnitzky A., Manson J.E. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med. 122:1995;481-486.
4. Willett W.C., Manson J.E., Stampfer M.J., Colditz G.A., Rosner B., Speizer E.E., et al. Weight change and coronary heart disease in women risk within the "normal" range . JAMA. 273:1995;461-465.
5. Froen J.F., Arnestad M., Frey K., Vege A., Saugstad O.D., Stray-Pedersen B. Risk factors for sudden intrauterine unexplained death epidemiologic characteristics of singleton cases in Oslo, Norway, 1986-1995 . Am J Obstet Gynecol. 184:2001;694-702.
6. Huang D.Y., Usher R.H., Kramer M.S., Yang H., Morin L., Fretts R.C. Determinants of unexplained antepartum fetal deaths. Obstet Gynecol. 95:2000;215-221.
7. Norman R.J., Clark A.M. Obesity and reproductive disorders a review . Reprod Fertil Dev. 10:1998;55-63.
8. Wang J.X., Davies M.J., Norman R.J. Obesity increases the risk of spontaneous abortion during infertility treatment. Obes Res. 10:2002;551-554.
9. Franks S., Hamilton-Fairley D. The role of body weight and metabolic anomalies in ovulation induction. Contracept Fertil Sex. 22:1994;178-179.
10. Hamilton-Fairley D., Kiddy D., Watson H., Paterson C., Franks S. Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin. Br J Obstet Gynaecol. 99:1992;128-131.
11. Wang J.X., Davies M.J., Norman R.J. Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment. Hum Reprod. 16:2001;2606-2609.
12. Fedorcsak P., Storeng R., Dale P.O., Tanbo T., Abyholm T. Obesity is a risk factor for early pregnancy loss after IVF or ICSI. Acta Obstet Gynecol Scand. 79:2000;43-48.
13. Bussen S., Sütterlin M., Steck T. Endocrine abnormalities during the follicular phase in women with recurrent spontaneous abortion. Hum Reprod. 14:1999;18-20.
14. Nardo L.G., Rai R., Backos M., El-Gaddal S., Regan L. High serum luteinizing hormone and testosterone concentrations do not predict pregnancy outcome in women with recurrent miscarriage. Fertil Steril. 77:2002;348-352.
15. Lashen H., Ledger W., Bernal A.L., Barlow D. Extremes of body mass do not adversely affect the outcome of superovulation and in-vitro fertilization. Hum Reprod. 14:1999;712-715.
16. al-Ansary L.A., Babay Z.A. Risk factors for spontaneous abortion a preliminary study on Saudi women . J R Soc Health. 114:1994;188-193.
17. Risch H.A., Weiss N.S., Clarke E.A., Miller A.B. Risk factors for spontaneous abortion and its recurrence. Am J Epidemiol. 128:1988;420-430.
18. Balen A.H., Tan S.L., MacDougall J., Jacobs H.S. Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin. Hum Reprod. 8:1993;959-964.
19. Tarlatzis B.C., Grimbizis G., Pournaropoulos F., Bontis J., Lagos S., Spanos E., et al. The prognostic value of basal luteinizing hormone follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques . Hum Reprod. 10:1995;2545-2549.
20. Glueck C.J., Wang P., Fontaine R.N., Sieve-Smith L., Tracy T., Moore S.K. Plasminogen activator inhibitor activity an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome . Metabolism. 48:1999;1589-1595.
21. Glueck C.J., Awadalla S.G., Phillips H., Cameron D., Wang P., Fontaine R.N. Polycystic ovary syndrome, infertility, familiar hypofibrinolisis, recurrent loss of in vitro fertilized embryos, and miscarriage. Fertil Steril. 74:2000;394-397.
22. Glueck C.J., Phillips H., Cameron D., Sieve-Smith L., Wang P. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion a pilot study . Fertil Steril. 75:2001;46-52.
23. Watson H., Kiddy D.S., Hamilton-Fairley D., Scanlon M.J., Barnard C., Collins W.P., et al. Hypersecretion of luteinizing hormone and ovarian steroids in women with recurrent early miscarriage. Hum Reprod. 8:1993;829-833.
24. Nestler J.E., Stovall D., Akhter N., Iuorno M.J., Jakubowicz D.J. Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome. Fertil Steril. 77:2002;209-215.
25. Gray R.H., Wu L.Y. Subfertility and risk of spontaneous abortion. Am J Pub Health. 90:2000;1452-1454.
26. Regan L., Braude P.R., Trembath P.L. Influence of past reproductive performance on risk of spontaneous abortion. Br Med J. 299:1989;541-545.
27. Pasquali R., Casimirri F., Vicennati V. Weight control and its beneficial effect on fertility in women with obesity and polycystic ovary syndrome. Hum Reprod. 12:1997;82-87.
28. Solomon C.G. The epidemiology of polycystic ovary syndrome. Prevalence and associated disease risks. Endocrinol Metab Clin North Am. 28:1999;247-263.
29. Li T.C., Serle E., Warren M.A., Cooke I.D. Is endometrial development in peri-implantation period influenced by high concentrations of luteinizing hormone in the follicular phase? Hum Reprod. 8:1993;1021-1024.
30. Okon M.A., Laird S.M., Tuckerman E.M., Li T.C. Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function. Fertil Steril. 69:1998;682-690.
31. Jakubowicz D.J., Seppala M., Jakubowicz S., Rodríguez-Armas O., Rivas-Santiago A., Koistinen H., et al. Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome. J Clin Endocrinol Metab. 86:2001;1126-1133.
32. Campbell P.J., Gerich J.E. Impact of obesity on insulin action in volunteers with normal glucose tolerance demonstration of a threshold for the adverse effect of obesity . J Clin Endocrinol Metab. 70:1990;1114-1118.
33. Bray G.A. Obesity and reproduction. Hum Reprod. 12:1997;26-32.
34. Bruning J.C., Gautam D., Burks D.J., Gillette J., Schubert M., Orban P.C., et al. Role of brain insulin receptor in control of body weight and reproduction. Science. 289:2000;2122-2125.
35. Burks D.J., de Mora J.F., Schubert M., Whiters D.J., Myers M.G., Towery H.H., et al. IRS-2 pathways integrate female reproduction and energy homeostasis. Nature. 407:2000;377-382.
36. Moschos S., Chan J.L., Mantzoros C.S. Leptin and reproduction a review . Fertil Steril. 77:2002;433-444.
37. Remohí J., Vidal A., Pellicer A. Oocyte donation in low responders to conventional ovarian stimulation for in vitro fertilization. Fertil Steril. 59:1993;1208-1215.
38. Ashkenazi J., Farhi J., Orvieto R., Homburg R., Dekel A., Feldberg D., et al. Polycystic ovarian syndrome patients as oocyte donors the effect of ovarian stimulation protocol on the implantation rate of the recipient . Fertil Steril. 64:1995;564-567.
39. Cano F., García-Velasco J.A., Millet A., Remohí J., Simón C., Pellicer A. Oocyte quality in polycystic ovaries revisited identification of a particular subgroup of women . J Assist Reprod Genet. 14:1997;254-261.
40. Díaz I., Navarro J., Blasco L., Simón C., Pellicer A., Remohí J. Impact of stage III-IV endometriosis on recipients of sibling oocytes matched case-control study . Fertil Steril. 74:2000;31-34.
41. Wang J.X., Davies M., Norman R.J. Body mass and probability of pregnancy during assisted reproduction treatment retrospective study . Br Med J. 321:2000;1320-1321.
42. Kurysheva K.A., Kolgushkin G.A., Georgadze G.R., Stol'nikova I.I., Vorgova T.M. The preclinical diagnosis of threatened abortion and late gestosis in pregnant women with normal body weight and obesity. Akush Ginecol (Mosk). 2:1994;17-19.
43. Clifford K., Rai R., Watson H., Franks S., Regan L. Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial. Br Med J. 312:1996;1508-1511.
44. Rai R., Backos M., Rushworth F., Regan L. Polycystic ovaries and recurrent miscarriage - a reappraisal. Hum Reprod. 15:2000;612-615.
45. Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Roberts KA, Nestler JE. Metformin reduces early pregnancy loss in polycystic ovary syndrome (abstract no. P2-147). In: Program and abstracts of the 83rd annual meeting of the Endocrine Society, Denver, Colorado 2001:384.
46. Jakubowicz D.J., Iuomo M.J., Jakubowicz S., Roberts K.A., Nestler J.E. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab. 87:2002;524-529.
47. Frisch R.E. The right weight body fat, menarche and ovulation . Ballieres Clin Gynaecol. 4:1990;419-439.
48. Tataranni P.A., Monroe M.B., Dueck C.A. Adiposity, plasma leptin concentration and reproductive function in active and sedentary females. Int J Obs Relat Metab Disord. 21:1997;818-821.
49. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature. 372:1994;425-432.
50. Ingalls A.M., Dickie M.M., Snell G.D. Obese, a new mutation in the house mouse. J Hered. 41:1950;317-318.
51. Barash I.A., Cheung C.C., Weigle D.S. Leptin is a metabolic signal to the reproductive system. Endocrinology. 137:1996;3144-3147.
52. Chehab F.F., Lim M.E., Ronghue L. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet. 12:1996;318-320.